CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 246 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,691,890 | -13.0% | 144,730 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $1,945,170 | -18.9% | 144,730 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2,399,620 | -10.9% | 144,730 | 0.0% | 0.00% | -25.0% |
Q4 2022 | $2,691,980 | +48.4% | 144,730 | +2.4% | 0.00% | +33.3% |
Q3 2022 | $1,814,000 | +86.8% | 141,379 | +2.0% | 0.00% | +200.0% |
Q2 2022 | $971,000 | +54.6% | 138,558 | +82.9% | 0.00% | 0.0% |
Q1 2022 | $628,000 | – | 75,746 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |